Insider: Kintz Samuel PRESIDENT AND CEO - Enliven Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 5,319 | 919,092 | 924,411 |
| Value | $98,773.83 | $17,067,538.44 | $17,166,312.27 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/23/2025 | DDS | 2,800 | Indirect | COM | $20.03 | $56,084.00 | 919,092 |
| 09/19/2025 | DDS | 1,000 | Indirect | COM | $20.25 | $20,250.00 | 921,892 |
| 09/17/2025 | DDS | 5,000 | Indirect | COM | $19.09 | $95,473.00 | 922,892 |
| 08/19/2025 | DDS | 590 | Indirect | COM | $20.00 | $11,800.00 | 929,409 |
| 08/18/2025 | DDS | 10,393 | Indirect | COM | $20.02 | $208,106.31 | 929,999 |
| 07/17/2025 | DDS | 3,663 | Indirect | COM | $23.37 | $85,606.51 | 940,392 |
| 07/17/2025 | DDS | 4,150 | Indirect | COM | $21.58 | $89,551.61 | 948,742 |
| 07/17/2025 | DDS | 4,687 | Indirect | COM | $22.69 | $106,359.75 | 944,055 |
| 06/17/2025 | DDS | 10,502 | Indirect | COM | $22.08 | $231,839.00 | 954,890 |
| 06/17/2025 | DDS | 1,998 | Indirect | COM | $22.75 | $45,453.30 | 952,892 |
| 06/03/2025 | DDS | 7,500 | Indirect | COM | $20.05 | $150,351.75 | 965,392 |
| 05/19/2025 | DDS | 5,000 | Indirect | COM | $16.49 | $82,453.00 | 972,892 |
| 05/02/2025 | DDS | 2,170 | Indirect | COM | $20.00 | $43,408.68 | 977,892 |
| 05/01/2025 | DDS | 5,330 | Indirect | COM | $20.08 | $107,006.68 | 980,062 |
| 04/17/2025 | DDS | 5,000 | Indirect | COM | $16.42 | $82,096.00 | 985,392 |
| 03/17/2025 | DDS | 12,500 | Indirect | COM | $20.83 | $260,320.00 | 990,392 |
| 10/18/2024 | DDS | 924 | Indirect | COM | $30.00 | $27,722.68 | 1,002,892 |
| 10/09/2024 | DDS | 13,880 | Indirect | COM | $28.07 | $389,675.45 | 1,006,646 |
| 10/09/2024 | DDS | 2,830 | Indirect | COM | $28.53 | $80,729.71 | 1,003,816 |
| 10/08/2024 | DDS | 13,167 | Indirect | COM | $27.95 | $368,078.22 | 1,020,626 |
| 10/08/2024 | DDS | 100 | Indirect | COM | $28.51 | $2,851.00 | 1,020,526 |
| 10/01/2024 | DDS | 526 | Indirect | COM | $27.54 | $14,484.51 | 1,048,729 |
| 08/26/2024 | DDS | 12,000 | Indirect | COM | $22.89 | $274,718.40 | 1,049,255 |
| 07/31/2024 | DDS | 2,270 | Indirect | COM | $27.56 | $62,555.07 | 1,061,255 |
| 06/25/2024 | DDS | 11,422 | Indirect | COM | $21.63 | $247,014.46 | 1,076,103 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research